Linde plc vs Ecolab Inc. — Stock Comparison
Q·Score Breakdown
7
Buy
Overall
6.6
Hold
Quality
Health
Growth
Valuation
Sentiment
LIN
High-quality business with 18% return on equity and 20% profit margins.
⚠ valuation offers limited margin of safety.
ECL
High-quality business with 22% return on equity and 13% profit margins.
⚠ balance sheet warrants attention.
Analyst Consensus
BUY
Target $525.49 (+4.2%)
25 analysts
BUY
Target $317.48 (+22.1%)
21 analysts
Fundamentals
LIN
ECL
34.6×
Trailing P/E
35.7×
25.8×
Forward P/E
27.1×
20.3%
Profit Margin
12.8%
48.8%
Gross Margin
44.4%
17.8%
ROE
22.4%
5.8%
Revenue Growth
10.0%
-9.4%
Earnings Growth
7.8%
0.79
Beta
1.02
—
Price / Book
—
$233.6B
Market Cap
$73.4B
$388 – $516
52-Week Range
$249 – $309
Q·Score is an educational tool and is not financial advice. Data provided by Yahoo Finance. Updated on each page load.